SAR 48.0
(0.0%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|
Revenue | 301.93 Million | 323.92 Million | 270.55 Million | 385.75 Million | 301.14 Million |
Cost of Revenue | 237.96 Million | 259.73 Million | 212.68 Million | 314.23 Million | 253.53 Million |
Gross Profit | 63.96 Million | 64.18 Million | 57.86 Million | 71.51 Million | 47.61 Million |
Operating Expenses | 30.02 Million | 23.78 Million | 21.97 Million | 19.85 Million | 21.27 Million |
Selling, General and Administrative Expenses | 30.11 Million | 23.78 Million | 21.97 Million | 19.38 Million | 21.27 Million |
Research and Development Expenses | - | - | - | - | - |
Other Expenses | -90.89 Thousand | 51.73 Thousand | 107.2 Thousand | -467.22 Thousand | - |
Cost and Expenses | 267.98 Million | 283.51 Million | 234.66 Million | 334.09 Million | 274.8 Million |
Operating Income | 33.94 Million | 40.4 Million | 35.88 Million | 51.65 Million | 26.34 Million |
Interest Expense | 306.15 Thousand | 7.94 Million | 4.84 Million | 3.96 Million | - |
Income Tax Expense | 3.71 Million | 3.48 Million | 2.57 Million | 3.04 Million | 1.99 Million |
Earnings before Tax | 19.67 Million | 32.51 Million | 30.83 Million | 47.73 Million | 20.66 Million |
Net Income | 15.95 Million | 29.02 Million | 28.26 Million | 44.69 Million | 18.66 Million |
Earnings Per Share Basic | 2.66 | 4.84 | 4.71 | 7.45 | 3.11 |
Earnings Per Share Diluted | 2.66 | 4.84 | 4.71 | 7.45 | 3.11 |
Weighted Average Shares Outstanding | 6 Million | 6 Million | 6 Million | 6 Million | 6 Million |
Weighted Average Shares Outstanding (Diluted) | 6 Million | 6 Million | 6 Million | 6 Million | 6 Million |
Gross Margin | 0.21 | 0.20 | 0.21 | 0.19 | 0.16 |
EBIT Margin | 0.13 | 0.12 | 0.13 | 0.14 | 0.10 |
Profit Margin | 0.05 | 0.09 | 0.10 | 0.12 | 0.06 |
EBITDA | 38.65 Million | 44.12 Million | 39.18 Million | 55.66 Million | 30.24 Million |
Earnings Before Tax Margin | 0.11 | 0.12 | 0.13 | 0.13 | 0.09 |
Breakdown | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 |
---|---|---|---|---|---|---|
Revenue | 301.93 Million | 73.51 Million | 73.51 Million | 77.44 Million | 77.44 Million | 78.85 Million |
Cost of Revenue | 237.96 Million | 55.31 Million | 55.31 Million | 63.66 Million | 63.66 Million | 61.6 Million |
Gross Profit | 63.96 Million | 18.2 Million | 18.2 Million | 13.78 Million | 13.78 Million | 17.24 Million |
Operating Expenses | 30.02 Million | 8.25 Million | 15.44 Million | 6.59 Million | 6.59 Million | 9.85 Million |
Selling, General and Administrative Expenses | - | 8.29 Million | 8.29 Million | 6.76 Million | 6.76 Million | 6.03 Million |
Research and Development Expenses | - | - | - | - | - | - |
Other Expenses | -30.02 Million | -45.44 Thousand | - | - | - | - |
Cost and Expenses | 267.98 Million | 63.56 Million | 70.76 Million | 70.25 Million | 70.25 Million | 71.46 Million |
Operating Income | 33.94 Million | 9.95 Million | 9.9 Million | 7.02 Million | 7.02 Million | 11.2 Million |
Interest Expense | 306.15 Thousand | - | - | - | - | 6.23 Million |
Income Tax Expense | 3.71 Million | 1.25 Million | 1.25 Million | 600 Thousand | 600 Thousand | 1.14 Million |
Earnings before Tax | 19.67 Million | 4.15 Million | 4.15 Million | 5.67 Million | 5.67 Million | 8.14 Million |
Net Income | 15.95 Million | 2.9 Million | 2.9 Million | 5.07 Million | 5.07 Million | 6.99 Million |
Earnings Per Share Basic | - | 0.48 | 0.48 | 0.85 | 0.85 | 1.17 |
Earnings Per Share Diluted | - | 0.48 | 0.48 | 0.85 | 0.85 | 1.17 |
Weighted Average Shares Outstanding | 6 Million | 6 Million | 6 Million | 6 Million | 6 Million | 6 Million |
Weighted Average Shares Outstanding (Diluted) | 6 Million | 6 Million | 6 Million | 6 Million | 6 Million | 6 Million |
Gross Margin | 0.21 | 0.25 | 0.25 | 0.18 | 0.18 | 0.22 |
EBIT Margin | - | 0.14 | 0.14 | 0.09 | 0.09 | 0.14 |
Profit Margin | 0.05 | 0.04 | 0.04 | 0.07 | 0.07 | 0.09 |
EBITDA | - | 9.99 Million | 9.99 Million | 7.1 Million | 7.1 Million | 11.28 Million |
Earnings Before Tax Margin | 0.11 | 0.14 | 0.13 | 0.09 | 0.09 | 0.14 |
CEVMF
MRAAF
002033
VPR
NPEGF
6677